The gut microbiota-miRNA axis in multiple sclerosis: Mechanisms and therapeutic potentials.
A better understanding of the GM-miRNA axis may facilitate the development of novel biomarkers and personalized therapeutic strategies, ultimately shifting MS management from symptomatic treatment toward precision, disease-modifying interventions.